|
2024
|
P/S
|
Pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting digestive organs;... |
|
|
P/S
|
Processed cereals; grain-based snack foods; confectionery made of sugar; granola-based snack bars... |
|
|
P/S
|
Non-alcoholic beers, non-alcoholic drinks containing fruit juices, carbonated non-alcoholic drink... |
|
|
P/S
|
Processed cereals; grain-based snack foods; confectionery; granola bars; diet tea; caffeine-free ... |
|
2020
|
Invention
|
Heteroaryl compounds and their use as therapeutic drugs. The present invention provides heterocyc... |
|
|
Invention
|
Heteroaryl compounds and their use as mer inhibitors. 24, X, L, n and p are as defined in the spe... |
|
2018
|
Invention
|
Aqueous formulation and in-syringe aqueous formulation, and antibody protein deaggregation agent ... |
|
|
Invention
|
Aqueous formulation, aqueous formulation in injector, antibody protein disaggregating agent, and ... |
|
2017
|
Invention
|
Heteroaryl compounds and their use as mer inhibitors. Compounds of formula (I) [Formula should be... |
|
2016
|
Invention
|
Heteroaryl compounds and their use as therapeutic drugs.
The present invention provide... |
|
2015
|
Invention
|
Stable aqueous adalimumab formulation.
The present invention provides a stable aqueous adalimuma... |
|
|
Invention
|
Stable aqueous adalimumab preparation. Provided is a stable aqueous adalimumab preparation that c... |
|
2014
|
Invention
|
Stabilized polypeptide aqueous preparation. The present invention relates to a stable etanercept ... |
|
|
Invention
|
Anti-vegf antibody, and pharmaceutical composition for preventing, diagnosing or treating cancer ... |
|
|
Invention
|
Anti-vegf antibody and pharmaceutical composition for prevention, diagnosis or treatment of cance... |
|
2006
|
Invention
|
Three-branched polyethylene glycol-g-csf conjugate. The present invention relates to three-branch... |
